Alkermes Plc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Alkermes Plc. on September 10, 2019, with the earliest event reported on that same date. The filing addresses significant changes to the composition of the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Director Resignation: Floyd E. Bloom, M.D., resigned from his role as a director of the Company, effective immediately on September 10, 2019.
- Board Expansion: On September 12, 2019, the Board of Directors increased the number of directors from nine to ten.
- New Director Elections: The Board elected Richard Gaynor, M.D., as a Class III director and Frank Anders (Andy) Wilson as a Class I director, both effective September 12, 2019.
Guidance, Outlook, and Compensation
Dr. Gaynor's term will expire at the 2020 annual general meeting, while Mr. Wilson's term will expire at the 2021 annual general meeting. Neither new director has been appointed to any Board committee as of the filing date. Compensation for the new directors includes a new director equity grant and an annual cash retainer and annual equity grant, pro-rated for their first year of service, in accordance with the Company's definitive proxy statement filed on April 5, 2019. The Company will also enter into deeds of indemnification with both new directors.
Key Facts for Investor Verification
- Verify the effective dates of the resignation of Dr. Bloom and the election of Dr. Gaynor and Mr. Wilson.
- Confirm the specific terms of the pro-rated equity grants and cash retainers for the new directors as detailed in the April 5, 2019 proxy statement.
- Monitor future filings for committee appointments for Dr. Gaynor and Mr. Wilson.
- Note that the press release regarding these events is furnished as Exhibit 99.1 and is not deemed "filed" under Section 18 of the Exchange Act.